Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer ; volume:23 ; number:1 ; day:26 ; month:1 ; year:2023 ; pages:1-7 ; date:12.2023
BMC endocrine disorders ; 23, Heft 1 (26.1.2023), 1-7, 12.2023
- Creator
-
Kiss, András
Szili, Balázs
Bakos, Bence
Ármós, Richárd
Putz, Zsuzsanna
Árvai, Kristóf
Kocsis-Deák, Barbara
Tobiás, Bálint
Balla, Bernadett
Pikó, Henriett
Dank, Magdolna
Kósa, János Pál
Takács, István
Lakatos, Péter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-023-01276-8
- URN
-
urn:nbn:de:101:1-2023040209142070862148
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kiss, András
- Szili, Balázs
- Bakos, Bence
- Ármós, Richárd
- Putz, Zsuzsanna
- Árvai, Kristóf
- Kocsis-Deák, Barbara
- Tobiás, Bálint
- Balla, Bernadett
- Pikó, Henriett
- Dank, Magdolna
- Kósa, János Pál
- Takács, István
- Lakatos, Péter
- SpringerLink (Online service)
Other Objects (12)
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer—a retrospective analysis
Lobo-isthmectomy in the management of differentiated thyroid cancer
The variable phenotype and low-risk nature of RAS-positive thyroid nodules
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer—a retrospective analysis
Lobo-isthmectomy in the management of differentiated thyroid cancer
The variable phenotype and low-risk nature of RAS-positive thyroid nodules
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer—a retrospective analysis
Lobo-isthmectomy in the management of differentiated thyroid cancer
The variable phenotype and low-risk nature of RAS-positive thyroid nodules
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer